Credit Suisse’s Sight Sciences SGHT Stock Holding History

Credit Suisse’s Portfolio SGHT Stock Details SGHT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-30,217	Closed	-$102K	–	3137
2023 Q3	$102K	Sell	30,217 -465	-2%	-$3.05K	﹤0.01%	3095
2023 Q2	$254K	Buy	30,682 +6,924	+29%	+$62.3K	﹤0.01%	3051
2023 Q1	$208K	Buy	23,758 +23,757	+2,375,700%	+$264K	﹤0.01%	3108
2022 Q4	$12	Sell	1 -120	-99%	-$1.14K	﹤0.01%	3717
2022 Q3	$1K	Buy	121 +98	+426%	+$829	﹤0.01%	3923
2022 Q2	$0	Buy	+23	New	+$202	﹤0.01%	4269

Other funds holding SGHT

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AMH

Apollo Management Holdings New York $7.6B AUM 23.97% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Credit Suisse's SGHT Position: Q4 2023 in Review

Credit Suisse sold out of Sight Sciences (SGHT) in Q4 2023, closing a stake of 30,217 shares — an estimated $102K sold.

Credit Suisse first reported a position in SGHT in Q2 2022 and held it in 6 quarters. The position peaked at $254K in Q2 2023. 65 funds tracked by Wall St. Rank hold SGHT as of Q4 2023.

Credit Suisse reported no remaining Sight Sciences position as of Q4 2023 after selling out during the quarter.
Credit Suisse sold 30,217 Sight Sciences shares in Q4 2023, an estimated $102K.
Credit Suisse first reported a position in Sight Sciences in Q2 2022 and held it in 6 quarters.
Credit Suisse's Sight Sciences position peaked at $254K in Q2 2023.
65 funds tracked by Wall St. Rank held Sight Sciences as of Q4 2023.

Based on Credit Suisse's 13F filing for Q4 2023, filed 8 Feb 2024.